Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias.

Arquivos de neuro-psiquiatria - 1 May 2022

Studart-Neto Adalberto, Coutinho Artur Martins

Abstract excerpt

Neurodegenerative dementias are characterized by the abnormal accumulation of misfolded proteins. However, its diagnostic criteria are still based on the clinical phenotype. The development of biomarkers allowed in vivo detection of pathophysiological processes. This article aims to make a non-systematic review of the use of molecular neuroimaging as a biomarker. Molecular neuroimaging is based on the use of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Amyloid beta-Peptides
Share to Fluorodeoxyglucose F18

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neuroimaging

Share to Phenotype

Share to Positron-Emission Tomography

Share to tau Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 35976328
DOI: 10.1590/0004-282X-ANP-2022-S138
PMCID: PMC9491407

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias.PMID 35976328Read ↗

Dissecting the Many Faces of Frontotemporal Dementia: An Imaging Perspective.Semantic proximity Read ↗

Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology.Semantic proximity Read ↗

Imaging frontotemporal lobar degeneration.Semantic proximity Read ↗

Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases.Semantic proximity Read ↗

Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET RadiotracersSemantic proximity Read ↗

Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.Semantic proximity Read ↗

Clinical phenotypes and genetic biomarkers of FTLD.Semantic proximity Read ↗

Incorporating new diagnostic schemas, genetics, and proteinopathy into the evaluation of frontotemporal degeneration.Semantic proximity Read ↗

Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnosticsSemantic proximity Read ↗

Positron emission tomography in vivo characterisation of the pathology of frontotemporal dementiaSemantic proximity Read ↗

Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology.Semantic proximity Read ↗

Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent InsightsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.